Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Selenium-75--19-selenocholesterol: a new adrenal scanning agent with high concentration in the adrenal medulla

Journal Article · · J. Nucl. Med., v. 17, no. 3, pp. 212-217
OSTI ID:4038828
A tissue distribution study with $sup 75$Se-19-selenocholesterol in rats, rabbits, and dogs showed high adrenal concentrations and good adrenal images. In the dog, higher concentrations were obtained in the adrenal medulla than in the cortex at Days 1 and 7 after dosing. Extraction and thin-layer chromatography of the adrenal lipid in dogs given this compound showed that $sup 75$Se in the adrenal is still attached to the steroid moiety. A reduction in production costs is expected from its longer shelf life. Selenium-75-19- selenocholesterol is being evaluated in humans not only for routine use as an adrenal cortex scanning agent, but also for the detection of pheochromocytomas and other sympathetic tissue tumors, especially neuroblastomas. (auth)
Research Organization:
Univ. of Michigan Medical Center, Ann Arbor
NSA Number:
NSA-33-029853
OSTI ID:
4038828
Journal Information:
J. Nucl. Med., v. 17, no. 3, pp. 212-217, Journal Name: J. Nucl. Med., v. 17, no. 3, pp. 212-217; ISSN JNMEA
Country of Publication:
United States
Language:
English

Similar Records

New and superior adrenal scanning agent, NP-59
Journal Article · Fri Oct 31 23:00:00 EST 1975 · J. Nucl. Med., v. 16, no. 11, pp. 1038-1042 · OSTI ID:4160305

Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines
Journal Article · Tue Jan 31 23:00:00 EST 1984 · J. Med. Chem.; (United States) · OSTI ID:6746983

Principles and management of adrenal cancer
Book · Wed Dec 31 23:00:00 EST 1986 · OSTI ID:5873602